17 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
members of the health care community of the effectiveness and safety of Notable’s drugs for their indicated applications and treatments;
Notable’s … , will be accepted by physicians, hospitals and other health care facilities. Volasertib and Fosciclopirox and any future drug candidates Notable develop
S-4/A
p3n9r
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
2r8a0
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.9
ypgcfl
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.2
k28zu0 8sv6hjiijfpo
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-1.1
b208h iwqi2uugaj16
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
xey drqicvyno7o2k3w
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.1
b936c921ynfs 5ksk4h1
8 Jul 21
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
4:05pm
6-K
EX-1.1
31rqzwiuy
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
20-F
EX-4.18
33zy1
25 Mar 15
Annual report (foreign)
12:00am
- Prev
- 1
- Next